Dr. David M. Brown, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- New York Medical College (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,092
Licensed in California since 2004, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: New York Medical College
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CA license A88545 (first issued 2004; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hoag Memorial Hospital Presbyterian Newport Beach, CA
- Prov Sacred Hrt Med Ctr & Childs Hosp. Spokane, WA
Medical groups
- Newport Neurohospitalist Medical Group, Inc (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,092
- Services billed
- 2,698
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 863 | 382 |
| Established patient office or other outpatient visit, 40-54 minutes | 545 | 357 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 443 | 420 |
| Advance care planning, first 30 minutes | 331 | 314 |
| Critical care, first 30-74 minutes | 145 | 101 |
| New patient office or other outpatient visit, 60-74 minutes | 57 | 57 |
| Telephone medical discussion with physician, 11-20 minutes | 37 | 34 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Newport Beach, CA | 298 |
| Niacin Er (niacin) Other prescribers in Newport Beach, CA | 176 |
| Gabapentin Other prescribers in Newport Beach, CA | 145 |
| Donepezil Hcl Other prescribers in Newport Beach, CA | 132 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Newport Beach, CA | 114 |
| Memantine Hcl Other prescribers in Newport Beach, CA | 111 |
| Venlafaxine Hcl Er (venlafaxine hcl) Other prescribers in Newport Beach, CA | 83 |
| Rosuvastatin Calcium Other prescribers in Newport Beach, CA | 79 |
| Escitalopram Oxalate Other prescribers in Newport Beach, CA | 65 |
| Rivastigmine (rivastigmine tartrate) Other prescribers in Newport Beach, CA | 54 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 6 payments worth $119 in total to this clinician.
| Alexion Pharmaceuticals, Inc. | $50.96 |
|---|---|
| UCB, Inc. | $30.00 |
| Microtransponder, Inc. | $20.40 |
| Axsome Therapeutics, Inc. | $17.55 |
| Food and Beverage | $88.91 |
|---|---|
| Education | $30.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| UCB, Inc. Mar 4, 2025 | Education Rystiggo · Neurology · in-kind | $15.00 |
| UCB, Inc. May 29, 2025 | Education Rystiggo · Neurology · in-kind | $15.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $23,700 in research payments for these studies, mostly to the institutions running them.
- A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.